Agenus To Present At Jefferies and Co. 2014 Global Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced that Robert Stein, MD, PhD, the company’s Chief Scientific Officer, is scheduled to present a company overview at the Jefferies 2014 Global Healthcare Conference in New York City on Thursday, June 5th at 1:00 pm ET.

Help employers find you! Check out all the jobs and post your resume.

Back to news